Navigation Links
IVCC develops new public health insecticides
Date:11/21/2010

The Innovative Vector Control Consortium (IVCC) has received $50 million from the Bill & Melinda Gates Foundation to continue its work to develop new insecticides for the improved control of mosquitoes and other insects which transmit malaria, dengue and other neglected tropical diseases.

IVCC was established in 2005 with an initial grant of $50.7 million over five years from the foundation. Since then, an unprecedented development pipeline of new, reformulated and repurposed insecticides has been established in partnership projects with leading global chemical companies. A suite of information systems and diagnostic tools for the more effective and efficient use of insecticides has also been developed, with these products now nearing the end of their development phase and being readied for rollout in the coming year.

The new five year grant will support new and ongoing projects to develop new Active Ingredients for insecticides and to complete the existing portfolio of insecticide formulation and repurposing projects.

Chief Executive Officer Professor Janet Hemingway explained: "The need for new insecticides has never been greater. Increased funding for control programmes is saving thousands of lives but malaria is still killing one child in Africa every 45 seconds. Resistance to insecticides is increasing at an alarming rate and we must find new alternatives even if we are to stay still in our battle against this and other vector borne diseases.

"This award allows us continue the pioneering work we're doing in partnership with the chemical industry to find and develop totally new classes of insecticide to help put an end to this needless loss of life. Our strategic aim is to provide three new Active Ingredients for use in public health insecticides by 2020."


'/>"/>

Contact: Alan Hughes
a.p.hughes@liv.ac.uk
44-151-705-3308
Liverpool School of Tropical Medicine
Source:Eurekalert

Page: 1

Related biology news :

1. NC State develops more precise genetic off switches
2. Yale develops new animal model for hemophilia A
3. Research develops simple recipe for fungus-free horseradish
4. CCNY-led team develops non-toxic oil recovery agent
5. Harvards Wyss Institute develops technology to produce sugar from photosynthetic bacteria
6. ISU researcher develops green, bio-based process for producing fuel additive
7. Military develops multi-purpose green decontaminants for terrorist attack sites
8. CSIRO develops highest-yielding salt-tolerant wheat
9. Tiny gold probes give scientists a sense of how disease develops
10. University of the Basque Country develops system for identifying illnesses in Paraguay
11. New strategy develops 2 prototype drugs against cancer, retinal diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... Lithuania , May 3, 2016  Neurotechnology, ... released the MegaMatcher Automated Biometric Identification System ... of large-scale multi-biometric projects. MegaMatcher ABIS can process ... accuracy using any combination of fingerprint, face or ... MegaMatcher SDK and MegaMatcher Accelerator ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/14/2016)... April 14, 2016 BioCatch ... Detection, today announced the appointment of Eyal Goldwerger ... role. Goldwerger,s leadership appointment comes at a ... of the deployment of its platform at several of ... technology, which discerns unique cognitive and physiological factors, is ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... ... its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced ... this eBook by providing practical tips, tools, and strategies for clinical researchers. , ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... MA (PRWEB) , ... June 23, 2016 , ... ... Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute ... platform of microbial tests introduced last year,” stated Bob Salter, Vice President of ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
Breaking Biology Technology: